Prev Close | 26.98 |
Open | 26.56 |
Day Low/High | 25.99 / 27.55 |
52 Wk Low/High | 7.02 / 29.37 |
Volume | 1.42M |
Prev Close | 26.98 |
Open | 26.56 |
Day Low/High | 25.99 / 27.55 |
52 Wk Low/High | 7.02 / 29.37 |
Volume | 1.42M |
Exchange | NYSE |
Shares Outstanding | 164.50B |
Market Cap | 4.66B |
P/E Ratio | N/A |
Div & Yield | N.A. (N.A) |
The deep-value Tax-Loss Selling Recovery Portfolio of a dozen stocks handsomely outperformed the S&P 500 and Russell 2000 indices.
Thanks to big gains by Tupperware Brands and GameStop these dozen stocks that languished in 2019 collectively are now up nicely since the portfolio's inception.
The idea behind this annual 'experiment' is to identify potentially 'cheap' names with 3 attributes.
There's progress for sure, but still a long way to go. Things could be worse.
This experiment in trying to identify stocks that could come back after dismal year-ago performance isn't going well five months since its inception.
Oil isn't really worthless and Amazon isn't the only retailer that will survive, but we are in a mixed up market thanks to Covid-19.
If investors reengage with these names in 2020, this could be an interesting set-up for market outperformance.
In this portfolio, the goal is for the winners to more than offset the losers.
We'll track a dozen beaten-up stocks that could be subject to tax-loss selling at the end of 2019 to see whether they can stage comebacks in 2020.
At the very end of December, the shorter of the two downtrend lines was violated suggesting a possible reversal at hand.
Kraft Heinz and DowDuPont spinoff Chemours offer attractive dividends and value potential.
The long correction in the chemicals company is over and traders can now go long on strength.
Beaten down pipeline MLP offers an attractive reward vs. risk profile.
We'll roll our CC profits into a November call spread.
The stock has been having a good year, but it's breaking out higher today.
At Libbey, the glass may be half empty, but it's likely to fill up again.
At Libbey, the glass may be half empty, but it's likely to fill up again.
Finding bullish and bearish reversals in the market.
We ought to open our eyes to what we don't care about, to what's still made here.
CC has made a strong upside move but more gains are anticipated in the weeks ahead.
Chemours is up over 153% year-to-date and more than 50% since a short-seller targeted the chemical maker.
When KKR and Apollo sell a stock it should be a huge red flag to investors to consider following suit.
Wall Street closed out the holiday-shortened week with a bang.
And that's distinctly good news for the overall market.
Shares of Chemours plunged on Friday on the heels of a bearish report written by short-seller Andrew Left of Citron Research.
U.S. markets falter Friday after an especially weak jobs report.
Andrew Left says he feels 'guilty' bringing up the stock issue when the humanitarian issue is much bigger.